Pharmafile Logo
Pharmafocus logo
Advanced Search

GI

Showing 4 posts of 4 posts found.

Takeda opens R&D facility in San Diego, California

May 2, 2019
Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …

News

Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m

December 13, 2018
Business Services GI, IBS, basuch, cnstipation, synergy pharma

Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …

News

Inflammatory bowel disease care ‘unacceptably’ variable

April 2, 2009
GI, NHS

The standard of care for patients with inflammatory bowel disease in the UK remains "unacceptably" variable. The second national audit …

News

P&G sponsors ulcerative colitis DVD

March 6, 2009
Sales and Marketing GI, digi

Procter & Gamble Pharmaceuticals is sponsoring and distributing a new educational DVD that aims to explain ulcerative colitis (UC) to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025